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Abstract
Background:  Economic valuations of health care programs often require using patients as
subjects, implying that research methodology should conform to the surrounding social, cultural
and ethical context. The significance of patients' opinions in health care decisions has been well
defined but in Greece, and perhaps elsewhere, clinicians remain skeptical. The purpose of this study
was to investigate, for the first time in Greece, the feasibility of measuring preference-based health-
state utilities and willingness to pay and to determine the context-based adaptations required to
overcome inherent elicitation problems.
Methods: A survey including a time trade-off (TTO), a standard gamble (SG), and two willingness-
to-pay (WTP) questions was self-administered to a homogenous group of 606 end stage renal
disease patients in 24 dialysis facilities throughout Greece and the overall response rate was 78.5%.
Typical elicitation methods were adapted to overcome methodological problems such as subjective
life expectancy and question framing. Spearman's correlation coefficients were calculated between
utilities and WTP and parametric tests (independent samples t-test and ANOVA) examined score
differences as a result of demographic and clinical factors.
Results: Mean health-state utilities were 72.56 (TTO) and 91.06 (SG) and these were statistically
significantly different (P  < 0.0005). Significant correlations, in the expected directions, were
observed between TTO – SG, TTO – WTP and SG – WTP (P < 0.01). High ceiling effects were
observed in the TTO and SG methods indicating patients' adversity to risk and unwillingness to
trade-off life years. Higher WTP was observed from younger patients (P < 0.0005), males (P < 0.05),
higher education levels (P < 0.01), single (P < 0.0005) and employed (P < 0.005).
Conclusion:  This study demonstrated, to a fair extent, that adapting research methods to
context-based particularities does not necessarily compromise results and should be considered in
situations where standard methods cannot be applied. On the other hand, it is emphasized that the
results from this study are preliminary and should be interpreted cautiously until further research
demonstrates the practicality, reliability and validity of alternative measurement approaches.
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Background
Bioethics has identified the significance of the patient's
opinion in health care decisions where facts known only
by doctors have to be supplemented by values known
only by patients. Pressures to improve the cost-effective-
ness of medical care have increased interest in perceived
health, health-related quality of life (HRQoL) and health-
state utilities as ways of bringing health assessment closer
to the patient's perspective. Despite conceptual and meth-
odological difficulties, the assessment of (HRQoL) can
assist in caring for chronically ill patients and the most
common measuring approach is using descriptive psycho-
metric instruments that describe health status in a number
of different areas. However, in cost utility analyses, where
it is desirable to measure overall HRQoL along a single
cardinal scale, descriptive instruments provide limited
information and health effects, in this case, are measured
usually in terms of quality-adjusted life years (QALYs) [1].
There are three main preference-based methods for meas-
uring QALY weights which are often referred to as health-
state utilities: the rating scale (RS), the time trade-off
(TTO) and the standard gamble (SG) [2]. Although the lit-
erature is rich in studies involving the elicitation of utili-
ties in many health care problems, only limited
information is available in the context of dialysis [3,4].
Contingent valuation (CV) is the commonly used direct
technique for eliciting willingness-to-pay (WTP). It
involves asking how much the respondent would be will-
ing to pay for the good in question. Values are derived by
setting up a hypothetical or contingent market for this
good which cannot be directly observed in a real market
place and the construction of this hypothetical market
will influence the values derived [5]. The literature con-
tains extensive reviews of CV studies in health care [6,7]
but to our knowledge it has not been previously applied
to dialysis patients.
It is clear that economic evaluations of health care pro-
grams often require the involvement of patients as sub-
jects, therefore it is important that the applied methods
are ethically sound and conform to existing social and cul-
tural conditions [8]. Furthermore, medical staff often
express methodological objections to studies they per-
ceive as inappropriate for their patients. These objections
often stem from the fact that physicians rely mostly on
objective clinical assessments and are hesitant to involve
patients in decision making processes [9]. In light of this,
it is important to adapt study methods to context-specific
barriers and overcome inherent application problems,
which would otherwise hinder such economic evalua-
tions.
This was the first study in Greece aiming to measure
health-state utilities and willingness to pay in any health
problem and the study population chosen was end stage
renal disease (ESRD) patients on dialysis. This patient
group was an attractive study option because the alterna-
tive of kidney transplantation could trigger their interest
to hypothetically trade time and wealth for better health.
The typical TTO, SG and WTP elicitation methods were
adapted to population and context-specific cultural and
ethical barriers. Given the overall uncertainty associated
with modifications to any standard research methodol-
ogy, the main objective of this study was to investigate the
feasibility, rather than the reliability or validity, of cultural
adaptations to the TTO, SG and WTP methods. It was
hypothesized that SG and TTO would positively correlate,
SG would produce higher scores, and both utilities would
negatively correlate with WTP in accordance to similar
studies involving other patient groups [10-13].
Health system and renal replacement therapy in Greece
A public-private mix for both funding and delivery cur-
rently characterizes the health care system in Greece. It is
financed by a combination of tax-based and insurance-
based statutory financing, supplemented by voluntary
funds, with the latter accounting for approximately 40%
of overall financing. The state budget, financed through
taxation at the central level only, is responsible for financ-
ing rural health center and rural clinic expenditures, sala-
ries of personnel in public hospitals, subsidies of public
hospitals (involving payments to hospitals over and
above the per diem fees paid by the health insurance
funds), subsidies of the social insurance funds, and subsi-
dies of civil servant health insurance, capital investments,
public health, medical education, etc. As for compulsory
health insurance there are approximately 30 funds, which
cover the bulk of the population. Membership is compul-
sory and based on occupation. Most of these funds are
public entities and, while autonomous, they operate
under extensive control by the central government and are
responsible for financing hospitals on a per diem basis
[14].
Currently, 9,500 patients are on some form of renal
replacement therapy (RRT) with approximately 75% on
long-term dialysis, 8% on peritoneal dialysis and the oth-
ers have been transplanted. The augmentation of the RRT
"pool" (taking into account patient deaths) is close to 8%
per annum. Regarding cost, dialysis is one of the most
expensive techniques in modern substitutive medicine. If
we are to accept the Greek estimate of €240 for the average
cost of a single dialysis session, then its aggregate eco-
nomic impact exceeds 250 million Euros per annum in
Greece. Of this, less than 10% is spent on technology,
while personnel account for the greatest part of the cost
[15]. Access to dialysis is free in both public and private
facilities and expenses are covered by health insurance.
The cost of a kidney transplantation, according to a recentBMC Health Services Research 2006, 6:3 http://www.biomedcentral.com/1472-6963/6/3
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(2003) estimation by the Hellenic National Transplant
Organization, is approximately €22,500.
Methods
Typical elicitation
In the SG method, QALY weights for health states are
determined by comparing a specific number of years in
health state Hi with a gamble (a treatment) offering two
reference outcomes, which are a probability p  of full
health for the same number of years and a probability 1-p
of immediate death. The probability p of full health is var-
ied until the respondent is indifferent between the two
alternatives. The indifference probability is the weight to
be assigned to health state Hi. On the other hand, the TTO
method typically requires comparing Y years in a particu-
lar health state Hi to X years in full health. The number X
is varied until the respondent is indifferent between the
alternatives. The QALY weight assigned to health state Hi
is then set equal to X/Y. The TTO and SG are choice-based
techniques that differ significantly in that TTO is riskless
whereas SG is framed in terms of risk and incorporates the
respondent's attitude towards risk. According to prospect
theory, attitudes towards risk consist of two components,
one of which reflects sensitivity to outcomes and the other
sensitivity towards chance [16].
On the other hand, WTP is the only benefit measure
reflecting conventional microeconomic properties and
requires respondents to consider a health-wealth tradeoff,
making it a cognitively more demanding method. It
imposes no restrictions on which attributes of a program
can be considered in its valuation [17]. Anything, over
which the individual has preferences, including a particu-
lar health outcome, is considered to be an "economic
good". Similarly to the QALY approach, the value of
reducing a specific mortality risk in the current period
depends on life expectancy, competing mortality risk and
the individuals's health if he/she is to survive the risk,
baseline risk and on income or wealth. Furthermore, a
person's WTP is clearly limited by his/her ability to pay
[18] and it has been shown that WTP is positively related
to income [19].
Ethical and cultural barriers
In most facilities the review boards and clinical staff, due
to perceived ethical considerations, refused to grant per-
mission for the patients to be subjected to questions
implying, even hypothetically, the age of death, i.e. the
timeframe Y mentioned previously. Religious issues had
to be considered also because the duration of life and time
of death are perceived as "unknowns" which are control-
led "from above" and not as tradable products. Further-
more, a specific timeframe, e.g. 10 or 20 years, could bias
the utility scores if subjective expectations about the age of
death were different [20]. In this study, the "gamble" was
a kidney transplant and the outcomes were a probability
p of full health and a probability 1-p of immediate death
with the latter again raising concern from clinical staff.
Ethical implications were foreseen in that the immediate
death probability 1-p could generate false perceptions to
patients about the actual risks associated with kidney
transplants and this, in turn, might result in increased
unwillingness from patients to undergo a transplant
should they have the opportunity to do so in a real-life sit-
uation.
In the Greek health system, as well as in most others
worldwide, the cost of dialysis treatments and kidney
transplants is fully covered by the public sources of financ-
ing and there are no existing co-payments required from
the patients. The ethical concern in the case of WTP was
that patients might become severely misconceived in that
they would be required to pay for a kidney transplant in a
real life situation. Given the overall low educational level
of the patients, many clinicians felt that the WTP ques-
tions could create a false impression about the existence of
an underlying "black-market" for transplants where the
wealthier and "better connected" could skip the waiting
list and "purchase" a kidney transplant.
Adapting study design
These objections had to be taken into account in design-
ing the study. The first methodology adaptation involved
offering the respondents health state Hi, (their current
health state) for the rest of their expected lifespan instead
of a fixed number of years. The difficulty in calculating
utilities, particularly in the case of TTO, came from the fact
that patients' remaining life years were unknown as this is
part of the contract of life. We adopted the "fair innings"
argument according to which all people are entitled to a
normal span of life [21] and encouraged patients to sub-
jectively assume that dialysis would secure for them a
number of life years similar to that of the general popula-
tion. For calculation, we arbitrarily assumed life expect-
ancy at 80 years of age without disclosing this information
to the patients. Those already older or willing to tradeoff
years which added to their current age, exceeded 80, were
excluded. In the case of SG, the problem was less compli-
cated since the fraction of remaining lifespan the individ-
ual would be willing to sacrifice to improve health does
not depend on the remaining lifespan, a condition known
as "constant proportional tradeoff longevity for health" [22].
In both SG and TTO, the health state to be assessed is
compared to an alternative that can be framed either as a
gain or a loss and it is well known, from many studies,
that the type of framing affects behavior, especially in the
case of the SG method [23]. The reason for this diversion
may be loss aversion, meaning that if a change is per-
ceived as a loss compared to a reference level, it results inBMC Health Services Research 2006, 6:3 http://www.biomedcentral.com/1472-6963/6/3
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a greater change in utility than if the same change is per-
ceived as a gain. Since dialysis patients are already in a less
than ideal health state it is easier for them to specify the
maximum probability 1-p  of the unfavorable outcome
rather than the minimum probability p of the favorable
one. This particular adaptation of the SG elicitation meth-
odology helped to overcome one more problem. Specifi-
cally, when outcomes are not certain but occur with
known probabilities, people transform these probabilities
into decision weights and in particular, they overestimate
small probabilities and underestimate large probabilities
[24].
Although the WTP methods used in this study are compa-
rable to those undertaken in other countries, the actual
elicitation techniques were chosen according to particu-
larities of the sample and concerns from the physicians.
Considering, once again, the low educational level of the
respondents and that WTP studies are, to date, practically
unknown in Greece, it was important that the elicitation
format not create suspicions about the intent of the ques-
tions. For example, the bidding game, in which an auction
process is simulated often resembling actual market situa-
tions, could make the patients uncomfortable and unwill-
ing to participate or even make them question if health
care is truly free. In any case, bidding games require inter-
viewers or interactive computer programs and are there-
fore more costly than other methods, which can be carried
out via self-administration.
In this study, WTP was measured using the dichotomous
format followed by an open-ended question, a technique
that has been shown to increase the statistical efficiency of
the responses [25]. Patients were initially asked if they
were willing to pay, out-of-pocket, €15,000 for a kidney
transplant. This bid is close to the actual cost of a kidney
The time trade-off, standard gamble and willingness to pay questions Figure 1
The time trade-off, standard gamble and willingness to pay questions.
1. Let’s assume you were presented with the following two scenarios and were asked to choose only one of them. Would 
you prefer to:
Remain in your current state of health for the rest of your expected life years?
or
Give up some of these life years and live fewer years but without the burden of your kidney disease? (Please
indicate how many life years you would be willing to give up in this case.)
2. As you are aware, kidney transplantation is the primary therapy for your condition, however it is sometimes
associated, theoretically at least, with the probability of death during or shortly after the operation. Please keep in mind
that this probability is actually very low and that this is only a hypothetical scenario. Would you prefer to:
Remain in your current state of health for the rest of your expected life years?
or
Undergo a kidney transplant, despite the probability of death during or shortly after the operation? (Please
indicate the maximum failure rate you would accept in this case. For example, stating 10% means that you 
would agree to be transplanted only if someone could “magically” guarantee 90% success.)
3. As you probably know, in our country as in most others as well, the cost of a kidney transplant is covered entirely by
the state and from insurance. This means that if you were to be transplanted, you would not be required to make any
payment. However, we are very interested in understanding how much you value a kidney transplant. Let us assume
you have the opportunity to undergo a transplant immediately but, hypothetically of course, you would be asked to pay 
for this with money out of your own pocket. Would you be willing to pay €15,000 for the transplant? Before answering,
keep in mind that paying this amount may result in your other individual or family needs not being fulfilled. We
remind you that this question is entirely hypothetical and that you will never be asked to pay any amount of money for
a transplant.
YES, I would be willing to pay €15,000 NO, I would not be willing to pay €15,000

Would you be willing to pay even more than
€15,000 for the transplant? If so, how much exactly?
Would you perhaps be willing to pay less than
€15,000 for the transplant? If so, how much exactly?BMC Health Services Research 2006, 6:3 http://www.biomedcentral.com/1472-6963/6/3
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transplant in Greece. It is unarguably a heavy economic
burden for the average Greek, however it is realistic and,
in most cases, could be raised with the help of the greater
family or friends. The objective was for respondents to
value the transplant in comparison to other personal and/
or family needs and produce realistic answers. In view of
this, they were advised to consider that paying this
amount would imply that other needs might not be satis-
fied. It was emphasized once more that the situation was
strictly hypothetical and no payments would be requested
in a real situation.
In a subsequent open-ended question, patients respond-
ing "yes" to the dichotomous question were asked if they
would be willing to pay more than €15,000 and, if so, to
specify the exact amount. Those answering "no" were
asked if they would be willing to pay a smaller amount
and again to specify. In cases where only the dichotomous
question was answered, the final WTP was taken as
€15,000 for the "yes" respondents whereas the "no"
respondents were taken as true zero bidders and included
in the analysis. The actual questions asked in this study
have been translated and are shown in Fig. 1.
Sample and data collection
We randomly selected 25% of the dialysis facilities cur-
rently operating in Greece (32 out of 128) and requested
permission to conduct the study using the standard elici-
tation methods. Each review board examined the survey
and only three granted immediate permission without
any methodological or ethical objections. The other
twenty-nine perceived at least one of the problems men-
tioned previously. We reapplied with the adapted versions
of elicitation, to overcome initial denial. This resulted in
twenty-one more facilities agreeing to participate (24 in
total – 75%), with the other eight remaining unconvinced
and eventually excluded. The adapted versions of elicita-
tion were used in all dialysis centers.
To facilitate a large population study without the need for
costly interviewers, the questions were paper-based for
self-administration, a technique that has been shown to
be a reliable substitute to typical utility elicitation meth-
ods in the case of SG [26,27]. As for WTP, self-administra-
tion is once again a logical substitute to the otherwise
preferred method of face-to-face interviews. However, the
latter represents the most costly way of collecting data
and, not surprisingly, in a review of 71 WTP surveys of
health and health care published in English during the
period of 1985-1998, only 27 (38%) employed face-to-
face data interviews compared to 34 (47.9%) employing
self-administration or post [28].
Each facility appointed a dialysis nurse who was trained to
distribute the questionnaire, explain the purpose of the
study and provide assistance when needed. Adult patients
(aged 18+) were eligible for the study and were chosen by
the clinical and nursing staff in each facility on the basis
of their mental and physical ability to read, comprehend
and complete the self-administered survey, with the least
possible assistance. Others not fulfilling this criteria, e.g.
minority groups or illiterates, were deemed unable to par-
ticipate. In order to ensure informed consent, the patients
were asked to read an accompanying letter emphasizing
that participation was voluntary and anonymous and that
only aggregate results would be reported. The survey con-
sisted of common socio-demographic and clinical ques-
tions, TTO and SG utility questions and two WTP
Table 1: Characteristics of the sample (N = 504)
Demographics N (% valid) Clinical data N (% valid)
Gender (male) 308 (61.6) Primary kidney disease
Age (mean ± SD) 57.1 ± 14.9 Glomerulonephritis 109 (22.2)
Education Polycystic kidney 60 (12.2)
Primary school 200 (42.6) Hypertension 97 (19.8)
Secondary school 80 (17.1) Diabetes 50 (10.2)
High school 119 (25.4) Other 84 (17.2)
University 70 (14.9) Unknown 90 (18.4)
Family status Years on HD (mean ± SD) 6.1 ± 5.6
Single 95 (19.0) On transplantation list 187 (37.6)
Married 339 (67.8) Previous unsuccessful transplant 52 (10.3)
Divorced/Separated 27 (5.4) Co morbidity 211 (41.9)
Widowed 39 (7.8) Cardiovascular disease 91 (43.1)
Occupational status Diabetes 46 (21.8)
Unemployed/Retired 226 (45.0) Physical impairment 20 (9.5)
Employed 195 (38.7) Other 54 (25.6)
Keeping house/Student 82 (16.3) One or more renal disease 
attributed hospitalizations over the 
past year
152 (30.1)BMC Health Services Research 2006, 6:3 http://www.biomedcentral.com/1472-6963/6/3
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questions. On aggregate, 606 dialysis patients from the 24
participating facilities were deemed suitable candidates.
The response rate was 78.5% with 504 patients eventually
completing the survey over the period April 2004 –
December 2004. Monetary values are reported in Euros
for 2004 (1€ = 1.3 USD).
Analysis
Spearman's correlation coefficients were used to analyze
the direction and the strength of the relationship between
the health-state utilities and willingness to pay. Paramet-
ric tests (independent samples t-test and ANOVA) were
performed to examine differences in scores, for each pref-
erence-based utility measure and WTP, as a result of vari-
ous socio-demographic and clinical factors such as age,
sex, education, familial status, employment, comorbidi-
ties and previous unsuccessful kidney transplant and mul-
tiple linear regression analysis was performed to
determine the most significant predictors. All analyses
were performed using SPSS software, version 12.0 (SPSS
Inc., Chicago IL).
Results
Socio-demographic and clinical characteristics of the sam-
ple (N = 504) are given in Table 1. The majority of
respondents were male (61.6%) and the mean age of the
whole sample was 57.1 years. Almost half had completed
only primary school and 14.9% percent had a university
education. Most patients were married (67.8%) and cur-
rently employed (38.7%). The average time on dialysis
treatment was 6.1 years and more than one third of the
sample was on the transplant waiting list. One out of ten
patients had already undergone an unsuccessful trans-
plantation and had returned to dialysis. Almost a third
had been hospitalized at least once over the past year for
reasons attributed to ESRD and 41.9% reported suffering
from at least one co-morbid condition.
The mean health-state utilities based on the TTO and SG
methods were 72.56 and 91.06 respectively (Table 2),
which were statistically significantly different (P  <
0.0005). The utility scores were further examined with
parametric tests (independent samples t-test and ANOVA)
in which age, sex, education, family/occupational status
and co-morbidities where used as grouping variables. Sig-
nificant differences (P < 0.05) were observed only with
age and interestingly older patients generated higher util-
ities with both methods. The high ceiling effects in the
TTO and SG methods are indications of patients' adversity
to risk and unwillingness to trade-off life years.
Concerning WTP, 40.5% of the respondents were unwill-
ing to pay any amount of money for a kidney transplant,
9.7% would pay up to €15,000, 18.8% percent would pay
exactly  €15,000 and 31.0% would pay more, with
€100,000 being the highest reported amount. The median
WTP for all participants was €10,000 (see Table 3). We
again examined mean WTP with independent samples t-
tests and ANOVA in order to assess if the same socio-
demographic and clinical factors were important determi-
nants and interestingly we found that all, except co-mor-
bidities, generated statistically significant differences.
Higher WTP was observed from younger patients (P <
0.0005), males (P < 0.05), higher education levels (P <
0.01), single (P < 0.0005) and employed (P < 0.005).
Multiple linear regression analysis, using a forward step-
wise selection procedure, was performed and the best-fit-
ting model incorporated age (P < 0.01) and family status
(P < 0.05) as significant predictors of WTP, providing an
explanatory power of 8.1%. The addition of various clini-
cal and health related variables as predictors had little
impact on the results.
Table 2: Central tendency and variability of utility measures
% N valid Mean 95% CI Median Std. Dev. Minimum Maximum % Floor % Ceiling
Utilities
Time Trade Off 78.0 72.56 69.43 – 75.70 88.10 31.61 0.00 1.00 2.0 47.3
Standard Gamble 91.1 91.06 89.86 – 92.26 95.00 13.09 0.25 1.00 0.2 47.3
Table 3: WTP frequency distribution and descriptive statistics
WTP (% N)
0 40.5%
< € 15,000 9.7%
= € 15,000 18.8%
> € 15,000 16.9%
> € 30,000 14.1%
Mean € 13,764
Standard deviation € 21,719
95% CI €11,863 – €15,665
Minimum 0
Maximum € 100,000
Percentiles
25 0
50 € 10,000
75 € 20,000BMC Health Services Research 2006, 6:3 http://www.biomedcentral.com/1472-6963/6/3
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It is also interesting that patients who had experienced an
unsuccessful kidney transplant were willing to pay
approximately 60% more than others who had never been
transplanted (P  < 0.05). Spearman's correlation coeffi-
cients between utility measures and willingness to pay are
presented in Table 4. We observed a strong positive asso-
ciation between TTO and SG and strong negative correla-
tions between WTP and the utility measures (P < 0.01).
The latter implies that, as expected, higher utility scores,
i.e. better quality of life, result in a reduced willingness to
pay.
Discussion
We applied utility elicitation and contingent valuation
methods to a sample of 504 dialysis patients. This was the
first study in Greece attempting to elicit WTP in any con-
text and also the first involving SG and TTO to value
health states. Previously, work has been performed in
Greece to translate and validate the EQ-5D instrument,
according to recommendations by the EuroQol Group.
The results indicated that the instrument is valid and reli-
able and can be used effectively in quality of life measure-
ment in Greek clinical trials and population-based
exercises [29]. However, the overall experience of the
Greek population with self-completion of health inter-
views is extremely limited and this constituted a major
factor requiring attention in this study.
The methods used here could be characterized as "non-
standard" in the sense that typical procedures, especially
in the case of SG and TTO, were modified to overcome
existing cultural and ethical barriers. The study demon-
strated the feasibility of measuring health-state utilities
and willingness to pay in this patient population, how-
ever it must be stressed that this does not ensure the valid-
ity of these methods and it is important to interpret the
results cautiously. We must take into consideration that
the reliability and validity of preference-based methods
could vary in a cross-cultural context due to differences in
the way an individual values health. This implies that the
comparability of results to those from other countries is
limited. Even more so in this case where methodological
adaptations were employed.
In accordance to the literature, the methods yielded sys-
tematically different results [30]. The cognitive processes
involved in eliciting patients' preferences for health out-
comes can be quite onerous and are affected by framing
effects, contexts, anchoring points, duration of condi-
tions, time preferences and attitudes towards risk [31,32].
Furthermore, willingness to tradeoff life years or to gam-
ble with life is dependent on how life and health are val-
ued by the respondent [33]. The patients in this study
were risk averse and unwilling to gamble and also unwill-
ing to trade many life years, as suggested by the ceiling
effects of TTO and SG scores. This could be due to reli-
gious factors or to the "coping mechanism" where
patients gradually learn to adapt to their situation and,
despite severe physical limitations, subjectively experi-
ence a relatively high HRQoL. On the technical side, the
high TTO and SG scores could be due to framing the alter-
natives as a loss, resulting in patients favoring their
present health state.
In an attempt to assess the validity of the measures, we
could follow the axioms of von Neumann and Morgen-
stern, where the SG method has a basis in expected utility
theory and is the standard technique for measuring deci-
sion making under uncertainty, implying that it gives a
valid health-state utility by definition [34]. In this study,
TTO showed a strong correlation with SG, therefore it
must also be relatively valid. However, it has been argued
that the SG results in a utility function that captures risk
attitudes, which implies that if a decision involves uncer-
tainty, the utility function should be used [35]. Providing
the absence of a gold standard, preference measurements
are value based, and hence, the weights used in cost-utility
studies will remain questionable and controversial. This
obviously applies to the present study as well.
Approximately 40% of the respondents were unwilling to
pay any amount for a kidney transplant and interestingly
75% of these "unwilling" patients were not on the trans-
plant list. Perhaps the awareness that they will not be
transplanted in the future makes them unwilling to even
hypothetically trade wealth for health. Indeed, the mean
age of "unwilling" and "willing" patients was 61.8 and
53.9 years respectively and the differences statistically sig-
nificant (P < 0.001). Almost 19% of all respondents were
willing to pay exactly the price set in the dichotomous
question, suggesting the existence of "yea-saying" bias, i.e.
the tendency of some respondents always to answer "yes"
irrespective of the price level [36-38]. We also observed
that patients who had undergone an unsuccessful trans-
plant were willing to pay approximately 60% more than
those never transplanted (P < 0.05). A possible explana-
tion is that experiencing the benefits of the transplant
even briefly, makes them less hesitant to consider a sec-
ond operation.
Table 4: Correlations between utilities and willingness to pay
Utilities SG WTP
Time Trade Off (TTO) 0.439** -0.198**
Standard Gamble (SG) -0.454**
** P < 0.01BMC Health Services Research 2006, 6:3 http://www.biomedcentral.com/1472-6963/6/3
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Willingness to pay was significantly (and negatively) cor-
related with both TTO and SG. This implies that higher
utility scores result in a reduced willingness to pay, and
this is both logical and expected, according to one of our
initial hypotheses. However, it is important to keep in
mind that the methods used to measure health-state util-
ities and willingness to pay are prone to large random
errors which eventually decrease correlations. In this
respect, an advantage of descriptive quality of life instru-
ments is that they are easy to administer and understand
which leads to lower random errors and higher reliability.
Given these advantages, it would be interesting to be able
to predict the results of health-state utility methods and
the willingness to pay methods based on the results from
quality of life instruments [39].
This study is not free from some limitations. We used an
ex post approach and an actual patient population to
assess WTP. While this approach is consistent with many
previous CV studies in the health field [40], some have
argued that WTP should be assessed ex ante from an insur-
ance perspective in which people from the general popu-
lation are informed about their own probabilities of
needing a service, and are asked about their ex ante insur-
ance premium payment, which focuses on option value
[41]. While the ex ante approach is recommended in the
health economics literature [42], the alternative approach
utilized in our study has several practical advantages. For
example, patients are better informed than the general
population about the consequences of a treatment and
therefore the CV questions should be easier to under-
stand. However, the absolute WTP values obtained should
be interpreted cautiously, since the current study may
have over- or under-estimated true WTP. In any case, the
aim was to investigate if correlations between WTP and
health state utilities elicited from non-standard methods
are as expected and, in this respect, the actual amounts
patients are willing to pay are not really important.
For ethical reasons previously mentioned, we set the time
frame as each patient's remaining lifetime and this could
have added a disturbing influence on the TTO utilities,
namely the effect of subjective expectations about the age
of death and quality of life. Patients have their own beliefs
about their expected age of death and future quality of life
but these expectations could be very different even
between patients of similar age and clinical condition and
in most cases different from the clinically expected dura-
tion of life [43]. In this respect, the SG method seems to
be advantageous as the time horizon specified in the ques-
tion is assumed to be independent of the QALY-utility
derived [44].
Conclusion
We generally suggest that adaptive study designs should
be considered in order to overcome methodological and
ideological objections from patients, review boards or
medical staff, but results should be examined cautiously
and critically. This is especially true in a study such as the
present involving methods, which are controversial even
in their standard form and alterations to typical practice
could create overall uncertainty. Despite this, our results
appear to conform to certain expected and hypothesized
patterns constituting them, at the very least, interesting.
Given the scarcity of utility studies and the non-existence
of WTP studies involving dialysis populations, further
research is necessary in order to test adapted methodolo-
gies and, more importantly, the meaningfulness of results.
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